Home>Topics>Stocks>Affymetrix

Affymetrix AFFX

  1. All
  2. Commentary
  3. Headlines
    1. Affymetrix estimates revenue below Street expectations, shares fall

      Headlines

      Mon, 8 Oct 2012

      (Reuters) - Affymetrix Inc estimated third-quarter revenue that was below Wall Street expectations, as tightening academic funding worldwide reduced sales at its gene expression and eBioscience...

    2. Dropping Coverage of Affymetrix

      Commentary

      Mon, 29 Aug 2011

      We are no longer providing equity research on Affymetrix AFFX . We provide broad coverage of more than 1,700 companies across more than 140 industries and adjust our coverage as necessary based on client demand and investor interest.

    3. Affymetrix shares fall on weak Q2 revenue view

      Headlines

      Thu, 7 Jul 2011

      (Reuters) - Shares of Affymetrix Inc fell about 20 percent on Thursday, a day after the genetic analysis products maker reported preliminary second-quarter revenue below market expectations.

    4. Affymetrix Turns Profit in 3Q

      Commentary

      Fri, 12 Nov 2010

      Affymetrix AFFX swung to profitability in the third ..... needle on our fair value estimate. Affymetrix reported $74 million in sales, 5 ..... cancer research. On the capital front, Affymetrix has continued to repurchase its convertible

    5. Revenue Drops in Affymetrix's 2Q

      Commentary

      Fri, 23 Jul 2010

      Affymetrix AFFX reported second-quarter results with revenue that came within its ..... Diagnostics to launch a colorectal cancer test. These efforts underpin Affymetrix 's efforts to focus investments on validation and diagnostic testing

    6. Affymetrix Lowers Revenue Outlook

      Commentary

      Wed, 7 Jul 2010

      Affymetrix AFFX today lowered its second-quarter revenue outlook to a range of $71 ..... decline. Lower second-quarter revenue will make it difficult for Affymetrix to achieve our full-year sales projections, and we are considering

    7. New Credit Rating: Illumina

      Commentary

      Wed, 23 Jun 2010

      ensure its dominance beyond the current technology cycle. For example, the recent downfall of former niche leader Affymetrix AFFX (rating: BB-) reads like a cautionary tale for Illumina creditors. Beyond those high business risks, we think

    8. New Credit Rating: Affymetrix

      Commentary

      Fri, 23 Apr 2010

      our issuer credit rating for Affymetrix AFFX at BB - , firmly in junk territory ..... genetic analysis niche , and Affymetrix has become a laggard , falling ..... before . While we still think Affymetrix will be able to sell its diagnostic

    9. In-Line 1Q for Affymetrix

      Commentary

      Thu, 22 Apr 2010

      Affymetrix AFFX reported first - quarter results in line with our expectations . We will maintain our fair value estimate as we still have worries

    10. Surprise Profit in Affymetrix's 4Q

      Commentary

      Thu, 4 Feb 2010

      Affymetrix AFFX produced a strong fourth quarter, topping our earnings projections and turning a profit. While we have improved our outlook for

    « Prev1234Next »
    Content Partners